On the other hand, as no loss of MSH6 expression was observed in the prostate tumor, this MSH6 variant is unlikely to explain the PrCa predisposition in this family, which is most likely related to the RAD51C truncation mutation or the ATM missense mutation also found in this patient. This evidence concerns the gene RAD51C and prostate neoplasm.